Resonance Health P/E 2024

Resonance Health Aktienanalyse

What does Resonance Health do?

Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Resonance Health's P/E Ratio

The Price to Earnings (P/E) Ratio of Resonance Health is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Resonance Health's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Resonance Health is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Resonance Health’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Resonance Health stock

What is the price-to-earnings ratio of Resonance Health?

The price-earnings ratio of Resonance Health is currently 177.09.

How has the price-earnings ratio of Resonance Health changed compared to last year?

The price-to-earnings ratio of Resonance Health has increased by -868.29% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Resonance Health high compared to other companies?

Yes, the price-to-earnings ratio of Resonance Health is high compared to other companies.

How does an increase in the price-earnings ratio of Resonance Health affect the company?

An increase in the price-earnings ratio of Resonance Health would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Resonance Health affect the company?

A decrease in the price-earnings ratio of Resonance Health would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Resonance Health?

Some factors that influence the price-earnings ratio of Resonance Health are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Resonance Health pay?

Over the past 12 months, Resonance Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Resonance Health is expected to pay a dividend of 0 AUD.

What is the dividend yield of Resonance Health?

The current dividend yield of Resonance Health is .

When does Resonance Health pay dividends?

Resonance Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Resonance Health?

Resonance Health paid dividends every year for the past 0 years.

What is the dividend of Resonance Health?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Resonance Health located?

Resonance Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Resonance Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Resonance Health from 9/17/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.

When did Resonance Health pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Resonance Health in the year 2023?

In the year 2023, Resonance Health distributed 0 AUD as dividends.

In which currency does Resonance Health pay out the dividend?

The dividends of Resonance Health are distributed in AUD.